Vimarsana
Biggest News Aggregation in the World

Page 3 - Founded Entity News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Founded Entity. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Founded Entity Today - Breaking & Trending Today

Why AAR Shares Are Trading Lower By 7%? Here Are Other Stocks Moving In Friday's Mid-Day Session - AAR (NYSE:AIR), Advent Technologies Hldgs (NASDAQ:ADN) - Vimarsana News

Why AAR Shares Are Trading Lower By 7%? Here Are Other Stocks Moving In Friday's Mid-Day Session - AAR (NYSE:AIR), Advent Technologies Hldgs (NASDAQ:ADN)

Shares of AAR Corp. (NYSE: AIR) fell during Friday’s session after the company reported mixed second-quarter financial results.

PureTech Health pipeline of new medicines poised for tremendous growth - Vimarsana News

PureTech Health pipeline of new medicines poised for tremendous growth

PureTech Health pipeline of new medicines poised for tremendous growth

PureTech Year End Update and Outlook for 2024 - Vimarsana News

PureTech Year End Update and Outlook for 2024

Strong strategic and clinical progress in 2023, with multiple catalysts expected in 2024 Launching of two new Founded Entities to advance certain programs from the Wholly Owned Pipeline Robust...

PureTech Founded Entity Karuna Therapeutics Announces U.S. Food and Drug Administration Accepts New Drug Application for KarXT for the Treatment of Schizophrenia - Vimarsana News

PureTech Founded Entity Karuna Therapeutics Announces U.S. Food and Drug Administration Accepts New Drug Application for KarXT for the Treatment of Schizophrenia

Prescription Drug User Fee Act action date is September 26, 2024 If approved, KarXT would represent the first new pharmacological approach to treating schizophrenia in several decades The...

PureTech Founded Entity Karuna Therapeutics Announces U.S. Food and Drug Administration Accepts New Drug Application for KarXT for the Treatment of S - Vimarsana News

PureTech Founded Entity Karuna Therapeutics Announces U.S. Food and Drug Administration Accepts New Drug Application for KarXT for the Treatment of S

PureTech Founded Entity Karuna Therapeutics Announces U.S. Food and Drug Administration Accepts New Drug Application for KarXT for the Treatment of Schizophrenia Prescription Drug User Fee Act (PDUFA) action date is September 26, 2024 If approved, KarXT would represent the first new pharmacological approach to treat...